The biopharmaceutical marketplace is characterized by change and uncertainty. Since commercialization is costly and time intensive, addressing fluctuating needs can be a challenge to pharmaceutical companies of any size. Outsourcing is a proven way of mitigating risk and attaining stability.
Outsourcing is an effective way to address unforeseen market challenges.
Outsourcing can also mitigate financial risk while maintaining stability.
Unforeseen events such as reimbursement or safety issues, or the market entry of a competitor can create immediate needs for increased share of voice. Commercialization solutions that seamlessly adapt to seasonal or geographic influences as well as unforeseen events require an underlying strategy and infrastructure that emphasizes scalability, cost reduction, and strategic flexibility.
The PDI Solution
One solution that addresses change seamlessly is to build part- and flex- time sales teams as an augmentation strategy. This allows for scaling up and down as the brand’s needs require without disruption of core teams. Scenarios in which representatives shift between sales and service functions, or shift between brands as required by market conditions also help provide flexibility. Most importantly, all these strategies preserve the expertise and cohesion of established teams over time.
PDI is an industry leader in designing and deploying flex teams.
Over the years, we have used part- and flex-time solutions in hundreds of customer-facing assignments. Flex-time professionals typically choose to work 20 to 24 hours in a 3-day work week for quality-of-life reasons. They are typically experienced, accomplished, and high-performing life science professionals. Members of flex teams are chosen for their commitment to a flex-time schedule, resulting in a very low turnover rate.
Shared and flex teams allow for stability.
Shared teams are designed to cover multiple products, whereas flex teams can move between sales and service roles.
For maximum flexibility, our inside teams are structured to allow quick “ramp ups” and “ramp downs” in response to developments in the market, such as:
- New product launch and competitive entries
- Generic competition, legal challenges, or regulatory issues
Find out how our flexible customer facing teams can help you address unforeseen challenges. Contact us now.